Literature DB >> 19036758

Risk factors and time delay associated with cardiac device infections: Leiden device registry.

J C Lekkerkerker1, C van Nieuwkoop, S A Trines, J G van der Bom, A Bernards, E T van de Velde, M Bootsma, K Zeppenfeld, J W Jukema, J-W Borleffs, M J Schalij, L van Erven.   

Abstract

AIMS: A nested case-control study of 75 patients with cardiac device infections (CDI) and 75 matched controls was conducted to evaluate time course, risk factors, culture results and frequency of CDI. METHODS AND
RESULTS: CDI occurred in 75/3410 (2.2%) device implantation and revision procedures, performed between 2000 and 2007. The time delay between device procedure and infection ranged from 0 to 64 months (mean 14 (SD 16)), 21 patients (28%) had an early infection (<1 month), 26 (35%) a late infection (1-12 months) and 28 (37%) a delayed infection (>12 months). Of interest, 18 (24%) patients presented with an infection >24 months after the device-related procedure. Time delay until infection was significantly shorter when cultures were positive for micro-organisms compared to negative cultures (8 (12) vs 18 (18) months, p = 0.03). Pocket cultures in delayed infections remained more often negative (61% vs 23%, p = 0.01). Independent CDI risk factors were: device revision (odds ratio (OR) 3.67; 95% confidence interval (CI), 1.51 to 8.96), renal dysfunction defined as glomerular filtration rate <60 ml/min (OR 4.64; CI, 1.48 to 14.62) and oral anticoagulation use (OR 2.83; CI 1.20 to 6.68).
CONCLUSION: CDI occurred in 2.2% of device procedures, with 24% occurring more than two years after the device-related procedure. Renal dysfunction, device revisions and oral anticoagulation are potent risk factors for CDI.

Entities:  

Mesh:

Year:  2008        PMID: 19036758     DOI: 10.1136/hrt.2008.151985

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  53 in total

1.  Cardiac implantable electronic devices in end-stage renal disease patients: preservation of central venous circulation.

Authors:  Gustavo Lopera; Gerald A Beathard; Jose Exaire; Roger Carrillo
Journal:  J Interv Card Electrophysiol       Date:  2012-06       Impact factor: 1.900

2.  Cardiac device infection due to Streptococcus pneumoniae.

Authors:  Theresa T Liu; Pablo B Nery; David Birnie; Peter Jessamine; Kathryn N Suh
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

3.  Cardiac device-related endocarditis caused by Paenibacillus glucanolyticus.

Authors:  Janina Ferrand; Tahar Hadou; Christine Selton-Suty; François Goehringer; Nicolas Sadoul; Corentine Alauzet; Alain Lozniewski
Journal:  J Clin Microbiol       Date:  2013-07-24       Impact factor: 5.948

4.  Efficacy of postoperative prophylactic antibiotics in reducing permanent pacemaker infections.

Authors:  Wen-Huang Lee; Ting-Chun Huang; Li-Jen Lin; Po-Tseng Lee; Chih-Chan Lin; Cheng-Han Lee; Ting-Hsing Chao; Yi-Heng Li; Ju-Yi Chen
Journal:  Clin Cardiol       Date:  2017-04-26       Impact factor: 2.882

5.  Cardiac Implantable Electronic Device Infection in Patients at Risk.

Authors:  Khaldoun G Tarakji; Christopher R Ellis; Pascal Defaye; Charles Kennergren
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-05

Review 6.  Self-powered cardiovascular electronic devices and systems.

Authors:  Qiang Zheng; Qizhu Tang; Zhong Lin Wang; Zhou Li
Journal:  Nat Rev Cardiol       Date:  2020-09-07       Impact factor: 32.419

7.  Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections.

Authors:  Muhammad R Sohail; Salwa Hussain; Katherine Y Le; Chadi Dib; Christine M Lohse; Paul A Friedman; David L Hayes; Daniel Z Uslan; Walter R Wilson; James M Steckelberg; Larry M Baddour
Journal:  J Interv Card Electrophysiol       Date:  2011-03-02       Impact factor: 1.900

8.  Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients.

Authors:  Matthew J Kolek; William F Dresen; Quinn S Wells; Christopher R Ellis
Journal:  Pacing Clin Electrophysiol       Date:  2012-12-17       Impact factor: 1.976

9.  Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects.

Authors:  Matthew J Kolek; Neel J Patel; Walter K Clair; S Patrick Whalen; Jeffrey N Rottman; Arvindh Kanagasundram; Sharon T Shen; Pablo J Saavedra; Juan C Estrada; Robert L Abraham; Christopher R Ellis
Journal:  J Cardiovasc Electrophysiol       Date:  2015-09-06

10.  Cardiac implantable electronic device infections: facts, current practice, and the unanswered questions.

Authors:  Khaldoun G Tarakji; Bruce L Wilkoff
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.